Vident Advisory LLC Boosts Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Vident Advisory LLC boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 21.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,327 shares of the biopharmaceutical company’s stock after purchasing an additional 232 shares during the period. Vident Advisory LLC’s holdings in Alnylam Pharmaceuticals were worth $312,000 at the […]
Vident Advisory LLC boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 21.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,327 shares of the biopharmaceutical company’s stock after purchasing an additional 232 shares during the period. Vident Advisory LLC’s holdings in Alnylam Pharmaceuticals were worth $312,000 at the […]
-tbk-logo-1200x675.png?v=20240515091022&w=240&h=240&zc=2){kind=logo}
